• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Pain Therapeutics Inc

+ Add to Watchlist

PX9:GR

1.693 EUR 0.045 2.73%

As of 09:30:35 ET on 12/23/2014.

Snapshot for Pain Therapeutics Inc (PX9)

Open: 1.645 Day's Range: 1.644 - 1.693 Volume: 1,775
Previous Close: 1.648 52wk Range: 1.000 - 4.362 1-Yr Rtn: -46.19%

Stock Chart for PX9

No chart data available.
  • PX9:GR 1.693
  • 1D
  • 1M
  • 1Y
1.648
Interactive PX9 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PX9

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.3000
Est. PEG Ratio -
Market Cap (M EUR) 77.47
Shares Outstanding (M) 45.76
30 Day Average Volume 386
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.7500
Dividend Ex-Date 12/13/2012
5 Year Dividend Growth -
Next Earnings Announcement 02/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PX9

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PX9

Pain Therapeutics, Inc. develops drugs using it proprietary technology. The Company develops safer or more efficacious drugs for use in pain management, particularly in the area of opioid painkillers. Pain Therapeutics has products in clinical trials.

Remi BarbierChairman/President/CEONadav FriedmannCOO/Chief Medical Officer
Peter S RoddyVP/CFO
More Company Profile & Key Executives for PX9

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil